在患有不同类型功能性排便障碍的患者中,直肠敏感性和相关因素
Yi-Bing Zhang1, Zhi-Yang Huang, Jian-Wei Jin
1Department of Gastroenterology, Wenzhou Central Hospital (the Dingli Clinical College of Wenzhou Medical University), Wenzhou, China.
European journal of gastroenterology & hepatology
|October 18, 2023
概括
在功能性排便障碍 (FDD) 亚型中,直肠敏感性下降. 年龄,便秘和糖尿病是关键的危险因素,而生物反治疗没有显示短期改善.
科学领域:
- 胃肠病学 胃肠病学
- 结肠直肠手术 结肠直肠手术
- 身体生理学 身体生理学
背景情况:
- 功能性排便障碍 (FDD) 包含各种排便模式障碍.
- 了解直肠敏感性对于管理FDD亚型至关重要.
研究的目的:
- 为了研究不同FDD亚型的直肠敏感性.
- 识别与直肠敏感性变化相关的因素.
- 评估生物反治疗对直肠敏感性的影响.
主要方法:
- 患有FDD的患者被分为失协性排便或不充分的排便推进组.
- 用直肠测量法评估了直肠敏感度.
- 后勤回归分析确定了直肠敏感性降低的风险因素.
主要成果:
- 在两种FDD亚型中,直肠敏感性都降低了,没有显著的群体间差异.
- 年龄,便秘症状评分和糖尿病是直肠敏感性降低的独立风险因素.
- 生物反疗法在短期内没有显著改变直肠敏感性参数.
结论:
- 直肠敏感性降低是FDD亚型的一个特征.
- 年龄,便秘和糖尿病是直肠敏感性减弱的重要危险因素.
- 短期生物反疗法在改善FDD的直肠过敏症方面无效.
相关概念视频
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
167
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
167
Assessment of the Rectum and Anus
241
Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
241
Irritable Bowel Syndrome I: Introduction
284
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
284
Chronic Bowel Disorders: Introduction
459
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
459
Feces Formation and Defecation
1.0K
After spending 3 to 10 hours in the large intestine, chyme loses a lot of water and becomes feces, the final product of digestion. Feces consist of undigested dietary fiber such as cellulose, mucus, sloughed-off epithelial cells, and microbes. The descending and sigmoid colon stores feces and uses haustral contractions to dry it out but retains enough water to give it a semi-solid texture.
The mass peristalsis then pushes the feces into the rectum, which stretches the rectal walls to activate...
The mass peristalsis then pushes the feces into the rectum, which stretches the rectal walls to activate...
1.0K
Drugs for Treatment of Diarrhea-Predominant IBS
186
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
186


